CD4+/CD56+hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement

被引:6
作者
Stetsenko, Galina Y. [1 ]
McFarlane, Rob [1 ]
Kalus, Andrea [2 ]
Olerud, John [2 ]
Cherian, Sindhu [3 ]
Fromm, Jonathan [3 ]
George, Evan [1 ]
Argenyi, Zsolt [1 ,2 ]
机构
[1] Univ Washington, Dept Pathol, Sch Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Dermatol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
关键词
D O I
10.1111/j.1600-0560.2007.00845.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
CD4+/CD56+ hematodermic neoplasm (HN), formerly known as a blastic natural killer (NK) cell lymphoma, is a rare subtype of a cutaneous dendritic cell neoplasm notable for highly aggressive behavior. The characteristic features are: expression of the T-helper/inducer cell marker CD4 and the NK-cell marker CD56 in the absence of other T cell or NK-cell specific markers. In particular, CD3 (surface or cytoplasmic) and CD2 are not expressed. Although T-cell receptor (TCR) genes are generally reported to be in a germline configuration, we present an unusual variant of a CD4+/CD56+ HN with a clonal rearrangement of TCR genes. This feature of a CD4+/CD56+ HN has been only rarely reported. Recognition of the presence of clonal TCR gene rearrangements in a small subset of CD4+/CD56+ HN is important to avoid misdiagnosis of this entity as an unusual variant of a cutaneous T-cell lymphoma.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 28 条
[1]   HIGH EXPRESSION OF CD56 (N-CAM) IN A PATIENT WITH CUTANEOUS CD4-POSITIVE LYMPHOMA [J].
ADACHI, M ;
MAEDA, K ;
TAKEKAWA, M ;
HINODA, Y ;
IMAI, K ;
SUGIYAMA, S ;
YACHI, A .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (04) :278-282
[2]  
[Anonymous], TUMOURS HAEMATOPOIET
[3]   Blastic NK-cell lymphoma/leukemia with T-cell receptor γ rearrangement [J].
Aoyama, Y ;
Yamane, T ;
Hino, M ;
Ohta, K ;
Nakamae, H ;
Yamamura, R ;
Koh, KR ;
Takubo, T ;
Inoue, T ;
Tatsumi, Y ;
Tatsumi, N .
ANNALS OF HEMATOLOGY, 2001, 80 (12) :752-754
[4]  
Assaf C, 2006, J CLIN PATHOL
[5]   Primary cutaneous natural killer/T-cell lymphoma [J].
Bastian, BC ;
Ott, G ;
Müller-Deubert, S ;
Bröcker, EB ;
Müller-Hermelink, HK .
ARCHIVES OF DERMATOLOGY, 1998, 134 (01) :109-111
[6]   CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature [J].
Bekkenk, MW ;
Jansen, PM ;
Meijer, CJLM ;
Willemze, R .
ANNALS OF ONCOLOGY, 2004, 15 (07) :1097-1108
[7]   Identification of a leukemic counterpart of the plasmacytoid dendritic cells [J].
Chaperot, L ;
Bendriss, N ;
Manches, O ;
Gressin, R ;
Maynadie, M ;
Trimoreau, F ;
Orfeuvre, H ;
Corront, B ;
Feuillard, J ;
Sotto, JJ ;
Bensa, JC ;
Brière, F ;
Plumas, J ;
Jacob, MC .
BLOOD, 2001, 97 (10) :3210-3217
[8]  
Cong PJ, 2001, MODERN PATHOL, V14, p160A
[9]   Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities [J].
Dijkman, Remco ;
van Doorn, Remco ;
Szuhai, Karoly ;
Willemze, Rein ;
Vermeer, Maarten H. ;
Tensen, Cornelis P. .
BLOOD, 2007, 109 (04) :1720-1727
[10]   Clinical and biologic features of CD4+CD56+ malignancies [J].
Feuillard, J ;
Jacob, MC ;
Valensi, F ;
Maynadié, M ;
Gressin, R ;
Chaperot, L ;
Arnoulet, C ;
Brignole-Baudouin, F ;
Drénou, B ;
Duchayne, E ;
Falkenrodt, A ;
Garand, R ;
Homolle, E ;
Husson, B ;
Kuhlein, E ;
Le Calvez, G ;
Sainty, D ;
Sotto, MF ;
Trimoreau, F ;
Béné, MC .
BLOOD, 2002, 99 (05) :1556-1563